latest news releases from the newsroom
Artificial Life, Inc.
Artificial Life Announces Over 1000 Active Sales Channels Under Contract
HONG KONG, May 29, 2008 (PRIME NEWSWIRE) -- Hong Kong-based Artificial Life, Inc. (OTCBB:ALIF) (www.artificial-life.com), a leading full service provider of award-winning mobile technology and applications, today announced that it has reached a major corporate development milestone by closing several new distribution contracts to reach and cover over 1000 active mobile sales channels for its products. The Company now sells its award winning 3G and other mobile products in more then 60 countries globally through on-deck telecom carrier channels as well as off-deck reseller and distributor channels.
Emergency Medical Associates
Emergency Medical Associates (EMA) Names Raymond Iannaccone, MD, FACEP as President and CEO of EMA and Affiliates
LIVINGSTON, N.J., May 29, 2008 (PRIME NEWSWIRE) -- Emergency Medical Associates (EMA), one of the country's premier, private, democratic emergency physician groups, is pleased to announce, after an intensive internal and external search, that it has named Raymond Iannaccone, MD, FACEP as President and CEO of Emergency Medical Associates and Affiliates.
Joy Global Inc.
Joy Global Inc. Announces Fiscal 2008 Second Quarter Operating Results
MILWAUKEE, May 29, 2008 (PRIME NEWSWIRE) -- Joy Global Inc. (Nasdaq:JOYG), a worldwide leader in high-productivity mining solutions, today reported results for the 2008 fiscal second quarter ended May 2, 2008. Orders were $1.2 billion, up 69% from $728 million in the prior-year period on strengthened conditions in the U.S. coal market and continued growing demand from the international markets. Net sales for the 2008 second quarter were $843 million compared to $629 million in the prior-year period, an increase of 34%.
Orckit Communications Ltd.
Orckit Announces 2008 Annual General Meeting
TEL AVIV, Israel, May 29, 2008 (PRIME NEWSWIRE) -- Orckit Communications Ltd. (Nasdaq:ORCT) today announced that its Annual General Meeting of Shareholders will be held on Thursday, July 3, 2008 at 3:00 p.m. Israel time, at the offices of the Company, 126 Yigal Allon Street, Tel Aviv, Israel. The record date for the meeting is June 3, 2008. Proxy statements describing the various matters on the agenda and proxy cards for use by shareholders that cannot attend the meeting in person will be sent by the mail to the Company's shareholders that hold shares registered with the American Stock Transfer & Trust Company, including shares held via DTC members.
Discovery Laboratories, Inc.
Discovery Labs and FDA to Meet On June 18, 2008 to Clarify Limited Items in SURFAXIN Approvable Letter
WARRINGTON, Pa., May 29, 2008 (PRIME NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), announced that it has received written notification from the U.S. Food and Drug Administration (FDA) that a meeting has been scheduled for June 18, 2008 via teleconference. This meeting is intended to confirm with the FDA Discovery Labs' approach to address the limited key remaining items necessary to gain U.S. marketing approval of SURFAXIN(r) (lucinactant) for the prevention of RDS in premature infants. On May 1, 2008, Discovery Labs received an Approvable Letter from the FDA for SURFAXIN that reflected notable progress towards gaining FDA approval.